A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Vedaprofen | Vedaprofen (Quadrisol) is a COX-1 selective nonsteroidal anti-inflammatory agent (NSAID) for serum TxB2 and exudate PGE2 inhibition [1]. Vedaprofen is a Escherichia coli ( E. coli ) sliding clamp (SC) inhibitor with the IC 50 of 222 μM [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Quadrisol; CERM 10202; PM 150. CAS No. 71109-09-6. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-118827. |  |
| Vedaprofen | Propionic acid type non-steroidal anti-inflammatory drug (NSAID). Group: Biochemicals. Grades: Highly Purified. CAS No. 71109-09-6. Pack Sizes: 2.5mg. US Biological Life Sciences. |  Worldwide |
| Vedaprofen | analytical standard. Group: Opiates / synthetic analgesic drug standardspharma & vet compounds & metabolitespharma & vet compounds & metaboliteseuropean pharmacopoeia (ph. eur.)pharmacopoeial standards. Alternative Names: (2RS)-2-(4-Cyclohexyl-1-naphthyl)propanoic acid,Vedaprofen. |  |
| Vedaprofen-d3 | Propionic acid type non-steroidal anti-inflammatory drug (NSAID). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Vedaprofen-d3 | analytical standard. Group: Opiates / synthetic analgesic drug standards. | |
| Vedolizumab | Vedolizumab is a monoclonal antibody developed by Millennium Pharmaceuticals for the treatment of ulcerative colitis and Crohn's disease under the trade name Entyvio. Vedolizumab binds to integrin α4β7 (LPAM-1) and blocks α4β7, displaying anti-inflammatory activity. Uses: The treatment of ulcerative colitis and crohn's disease. Synonyms: Entyvio. CAS No. 943609-66-3. Molecular formula: C6528H10072N1732O2042S42. Mole weight: 146836.67. |  |
| Vedolizumab | Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anti-Human lymphocyte α4β7 integrin, Humanized Antibody. CAS No. 943609-66-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9911. | |
| Vedolizumab (anti-α4β7-integrin) | Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 943609-66-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9911A. | |
| Vedroprevir | Vedroprevir is a selective hepatitis C virus (HCV) NS3 protease inhibitor. It is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1(GT1) infection. It inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion. It retained wild-type activity against multiple classes of NS5B and NS5A inhibitor resistance mutations. It showed good oral bioavailability in all three species tested. It was developed by Gilead Sciences and was terminated in clinic phase 2 trials. Uses: Vedroprevir is a pharmaceutical drug that is used in the treatment of hepatitis c virus in patients with hcv genotype 1(gt1) infection. Synonyms: GS9451; GS-9451; GS 9451; Vedroprevir; (1R,2R)-N-[[(1alpha,3beta,5alpha)-Bicyclo[3.1.0]hex-3-yloxy]carbonyl]-3-methyl-L-valyl-(4R)-4-[[8-chloro-2-[2-[(1-methylethyl)amino]-4-thiazolyl]-7-[2-(4-morpholinyl)ethoxy]-4-quinolinyl]oxy]-L-prolyl-1-amino-2-ethyl-cyclopropanecarboxylic acid;GS9451;GS-9451;(1R,2R)-1-((2S,4R)-1-((2S)-2-(((((1R,5S)-bicyclo[3.1.0]hexan-3-yl)oxy)carbonyl)amino)-3,3-dimethylbutanoyl)-4-((8-chloro-2-(2-(isopropylamino)thiazol-4-yl)-7-(2-morpholinoethoxy)quinolin-4-yl)oxy)pyrrolidine-2-carboxamido)-2-ethylcyclopropane-1-carboxylic acid. Grades: >98%. CAS No. 1098189-15-1. Molecular formula: C45H60ClN7O9S. Mole weight: 910.52. | |
| Veegum® | Magnesium Aluminum Silicate Type IC Veegum Hv. Grades: USP/NF. CAS No. 1327-43-1. Product ID: 8-01580. Properties: d 1.184. |  |
| Vegetable glycerol | 500ml Pack Size. Group: Analytical Reagents, Aroma Chemicals, Biochemicals, Flavours and Fragrance Materials, Organics, Solvents. Formula: HOCH2CH(OH)CH2OH. CAS No. 56-81-5. Prepack ID 90025553-500ml. Molecular Weight 92.09. See USA prepack pricing. |  |
| Vegetable oil | Pale yellow oily liquid with a weak, fatty odor. Floats on water. CAS No. 68956-68-3. Product ID: PE-0275. Category: Plasters Base. Product Keywords: Pharmaceutical Excipients; Semi-solid Dosage Form; Plasters Base; Vegetable oil; PE-0275; 68956-68-3; 68956-68-3. Appearance: Pale yellow oily liquid. EC Number: 273-313-5. Solubility: Insoluble in water. |  |
| Vegetable oil | Pale yellow oily liquid with a weak, fatty odor. Floats on water. CAS No. 68956-68-3. Product ID: PE-0172. Category: Filler. Product Keywords: Pharmaceutical Excipients; Solid Dosage Form; Capsule Excipients; Filler; Vegetable oil; PE-0172; 68956-68-3; 68956-68-3. Appearance: Pale yellow oily liquid. EC Number: 273-313-5. Solubility: Insoluble in water. | |
| Vegetable Oil, Hydrogenated | Hydrogenated vegetable oil is a mixture of triglycerides of fatty acids. The two types that are defined in the USP are characterized by their physical properties. Hydrogenated vegetable oil type I occurs in various forms, e.g.fine powder, flakes, or pellets. The color of the material depends on the manufacturing process and the form. In general, the material is white to yellowish-white with the powder grades appearing more white-colored than the coarser grades. Synonyms: Hydrogenated cottonseed oil: Akofine; Lubritab; Sterotex. CAS No. 68334-00-9. Product ID: PE-0444. Category: Dispersants. Product Keywords: Pharmaceutical Excipients; Excipients for Liquid Dosage Form; Vegetable Oil, Hydrogenated; Dispersion Excipients; Dispersants; 68334-00-9; 68334-00-9. UNII: NA. Chemical Name: Hydrogenated vegetable oil [68334-00-9]. Hydrogenated soybean oil [8016-70-4]. Grade: Pharmceutical Excipients. Administration route: Oral; rectal and vaginal and topical. Dosage Form: Oral capsules and tablets; rectal and vaginal suppositories and topical preparations. Stability and Storage Conditions: Hydrogenated vegetable oil type I is a stable material; typically it is assigned a 2-year shelf-life. The bulk material should be stored in a well-closed container in a cool, dry place. Source and Preparation: Hydrogenated vegetable oil type I is prepared from refined vegetable oils, which are hydrogenated using a catalyst. App | |
| VEGF165 from mouse | recombinant, expressed in E. coli. Group: Fluorescence/luminescence spectroscopy. | |
| VEGF165 from rat | recombinant, expressed in E. coli, ?98% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| VEGF165 human | recombinant, expressed in E. coli, ?98% (SDS-PAGE), ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| VEGF-C from mouse | recombinant, expressed in E. coli, ?90% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| VEGF-C from rat | recombinant, expressed in E. coli, ?90% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| VEGF-C human | recombinant, expressed in HEK 293 cells, ?95% (SDS-PAGE), ?95% (HPLC), suitable for cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| VEGF-C human | recombinant, expressed in E. coli, ?90% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| VEGF-D human | recombinant, expressed in HEK 293 cells, ?95% (SDS-PAGE), ?95% (HPLC), suitable for cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| VEGF human | Animal-component free, recombinant, expressed in E. coli, ?98% (SDS-PAGE), ?98% (HPLC), suitable for cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| VEGF Inhibitor, CBO-P11 | The VEGF Inhibitor, CBO-P11 controls the biological activity of VEGF. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGF Inhibitor, Flt???? | The VEGF Inhibitor, Flt2-11 controls the biological activity of VEGF. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGF Inhibitor, V1 | The VEGF Inhibitor, V1 controls the biological activity of VEGF. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGFR2/Flt3/c-Kit Inhibitor - CAS 796967-10-7 | The VEGFR2/Flt3/c-Kit Inhibitor, also referenced under CAS 796967-10-7, controls the biological activity of VEGFR2/Flt3/c-Kit. This small molecule/inhibitor is primarily used for Activators/Inducers applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGFR2-IN-2 | VEGFR2-IN-2 (compound 6e) is a potent and selective VEGFR2 inhibitor with an IC 50 of 19.32 nM. VEGFR2-IN-2 can be used for researching. Uses: Scientific research. Group: Signaling pathways. CAS No. 737818-56-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-147133. | |
| VEGFR-2-IN-29 | VEGFR-2-IN-29 (Compound 5) is a VEGFR-2 inhibitor with an IC 50 of 16.5 nM [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 62802-77-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-148040. | |
| VEGFR-2-IN-39 | VEGFR-2-IN-39 (PROTAC-5) is a PROTAC targeting VEGFR-2 ( IC 50 : 208.6 nM). VEGFR-2-IN-39 has low toxicity.VEGFR-2-IN-39 inhibits the proliferation of EA.hy926, one of HUVECs, in a concentration-dependent manner, with an IC 50 of 38.65 μM [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2353417-86-2. Pack Sizes: 5 mg; 10 mg. Product ID: HY-160259. | |
| VEGFR-2-IN-5 hydrochloride | VEGFR-2-IN-5 hydrochloride is a VEGFR2 inhibitor extracted from patent WO2013055780A1, Page 69 [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2700435-52-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-18625A. | |
| VEGFR2/KDR fragment 1 (614-624) | | |
| VEGFR2 Kinase Inhibitor I - CAS 15966-93-5 | The VEGFR2 Kinase Inhibitor I, also referenced under CAS 15966-93-5, controls the biological activity of VEGFR2 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGFR2 Kinase Inhibitor II | VEGFR2 kinase inhibitor II is a reversible and cell-permeable inhibitor of VEGFR2's kinase activity with IC50 value of 70 nM. It also less potently inhibits the platelet-derived growth factor receptor β (PDGFRβ) with IC50 value of 920 nM, and other related receptor as well as non-receptor tyrosine kinases. Synonyms: (Z)-5-Bromo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)-1,3-dihydroindol-2-one. Grades: ≥95%. CAS No. 288144-20-7. Molecular formula: C17H15BrN2O. Mole weight: 343.2. | |
| VEGFR2 Kinase Inhibitor II - CAS 288144-20-7 | The VEGFR2 Kinase Inhibitor II, also referenced under CAS 288144-20-7, controls the biological activity of VEGFR2 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGFR2 Kinase Inhibitor VII, SKLB1002 | The VEGFR2 Kinase Inhibitor VII, SKLB1002 controls the biological activity of VEGFR2 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGFR2 Kinase Inhibitor VII, SKLB1002 (VEGFR Tyrosine Kinase Inhibitor XXXV, 6,7-Dimethoxy-4-(5-methyl-1,3,4-thiadiazol-2-ylthio)quinazoline, Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor VII) | A cell-permeable quinazoline that acts as a potent, ATP-binding site-targeting, VEGFR2-selective inhibitor (IC50=32nM), while exhibiting much reduced or little activity against 16 other kinases. An effective antiangiogenesis agent (98% inhibition of HUVEC tube formation at 10uM; 80% inhibition of zebrafish embryos intersegmental vessel growth at 2.5uM) that significantly suppresses SW620- and HepG2-derived tumor growth in mice (by 72% and 63%, respectively, in 18 days; 100mg/kg/day; i.p.) in vivo. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| VEGFR2 Kinase Inhibitor VI, Ki8751 - CAS 228559-41-9 | The VEGFR2 Kinase Inhibitor VI, Ki8751, also referenced under CAS 228559-41-9, controls the biological activity of VEGFR2 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGFR3 Kinase Inhibitor, MAZ51 - CAS 163655-37-6 | The VEGFR3 Kinase Inhibitor, MAZ51, also referenced under CAS 163655-37-6, controls the biological activity of VEGFR3 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGF Receptor-1 (Flt-1)/Fc Chimera from mouse | ?90% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder, suitable for cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| VEGF Receptor-1 (Flt-1)/Fc Chimera human | >90% (SDS-PAGE), recombinant, expressed in baculovirus infected Sf21 cells, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| VEGF Receptor-2 (Flk-1, KDR)/Fc Chimera human | >90% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| VEGFR-IN-1 | VEGFR-IN-1 (compound 3) is a potent angiogenesis inhibitor with IC 50 s of 0.02, 0.18, 0.24 7.3, and 7 μM for KDR , Flt-1 , c-Kit, EGF-R, and c-Src, respectively [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 269390-69-4. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg. Product ID: HY-101219. | |
| VEGFR/Tie-2/PDGFR Tyrosine Kinase Inhibitor | The VEGFR/Tie-2/PDGFR Tyrosine Kinase Inhibitor controls the biological activity of VEGFR/Tie-2/PDGFR. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGFR Tyrosine Kinase Inhibitor II | VEGFR tyrosine kinase inhibitor II is a pyridinyl-anthranilamide compound that potently inhibits the kinase activities of VEGFR2 (KDR), VEGFR1 (FLT1), and c-Kit (IC50 = 20, 180, and 240 nM, respectively). It is potential for cancer treatment for its inhibitory effect of tumor induced angiogenesis. Synonyms: N-(4-Chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide. Grades: ≥98%. CAS No. 269390-69-4. Molecular formula: C19H16ClN3O. Mole weight: 337.8. | |
| VEGFR Tyrosine Kinase Inhibitor II - CAS 269390-69-4 | The VEGFR Tyrosine Kinase Inhibitor II, also referenced under CAS 269390-69-4, controls the biological activity of VEGFR Tyrosine Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGFR Tyrosine Kinase Inhibitor V | The VEGFR Tyrosine Kinase Inhibitor V controls the biological activity of VEGFR Tyrosine Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| VEGFR Tyrosine Kinase Inhibitor VI, AAL-993 - CAS 269390-77-4 | The VEGFR Tyrosine Kinse Inhibitor VI, ALL-993, also referenced under CAS 269390-77-4, controls the biological activity of VEGFR Tyrosine Kinase. This small molecule/inhibitor is primarily used for Cancer applications. Group: Fluorescence/luminescence spectroscopy. | |
| Vegita | Vegita is a metabolite of maneb, a fungicide. Synonyms: Hortocritt; Ethylenethiuramsulfide; Ethylenethiurammonosulfide; ETM(heterocycle); ETEM. Grades: 95%. CAS No. 33813-20-6. Molecular formula: C4H4N2S3. Mole weight: 176.28. | |
| Vejovine (23-82) | Vejovine (23-82) is a new type of antibiotic peptide derived from scorpion venom, which shows significant and effective antibacterial activity against clinical isolates of Gram-negative multi-drug resistant strains of Escherichia coli, Pseudomonas aerμginosa and Acinetobacter baumannii. Synonyms: Gly-Ile-Trp-Ser-Ser-Ile-Lys-Asn-Leu-Ala-Ser-Lys-Ala-Trp-Asn-Ser-Asp-Ile-Gly-Gln-Ser-Leu-Arg-Asn-Lys-Ala-Ala-Gly-Ala-Ile-Asn-Lys-Phe-Val-Ala-Asp-Lys-Ile-Gly-Val-Thr-Pro-Ser-Gln-Ala-Ala-Ser-Met-Thr-Leu-Asp-Glu-Ile-Val-Asp-Ala-Met-Tyr-Tyr-Asp. | |
| VEL-0230 | VEL-0230, also known as NC-2300, is a potent cathespin K inhibitor. VEL-0230 has dual-acting properties that both stimulates bone formation and inhibits loss. VEL-0230 is being studied preclinically for the treatment of diseases involving bone mineral disorders such as bone loss related to multiple myeloma, osteoporosis, bone metastases, and rheumatoid arthritis. Velcura Therapeutics is currently being developed by Velcura Therapeutics. Given VEL- 0230's promotion of bone formation, inhibition of bone loss and reduction of calcium levels, Velcura has chosen Myeloma as its lead indication, as the bone fragility, bone pain, high calcium levels and eventual kidney involvement present serious medical and quality of life issues to affected patients. Synonyms: VEL 0230; VEL0230; NC-2300; NC2300; NC 2300; sodium (2S,3S)-3-(((S)-1-isobutoxy-4-methylpentan-2-yl)carbamoyl)oxirane-2-carboxylate. CAS No. 221144-20-3. Molecular formula: C14H24NNaO5. Mole weight: 309.33. | |
| Velagliflozin | Velagliflozin is an orally available sodium-glucose cotransporter 2 ( SGLT2 ) inhibitor, with anti-diabetic activity. Uses: Scientific research. Group: Signaling pathways. CAS No. 946525-65-1. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg. Product ID: HY-109018. | |
| Velagliflozin proline | Velagliflozin proline is an oral sodium-glucose cotransporter 2 ( SGLT2 ) inhibitor with antidiabetic activity. Velagliflozin proline reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1539295-26-5. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg. Product ID: HY-109018A. | |
| Veldoreotide TFA | Veldoreotide (DG3173) TFA a somatostatin analogue, binds to and activate the somatostatin receptors (SSTR) 2, 4, and 5. Veldoreotide TFA inhibits growth hormone (GH) secretion in adenomas compared with Octreotide (HY-P0036). Veldoreotide has the potential to be used as pain modulating agent [1]. Uses: Scientific research. Group: Peptides. Alternative Names: DG3173 TFA; PTR-3173 TFA. CAS No. 2126831-23-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P0024A. | |
| Veledimex | Veledimex is used as an immunostimulant drug candidate. Uses: Veledimex is used as an immunostimulant drug candidate. Synonyms: AD-1001; AD1001; AD 1001; INXN-1001;INXN1001; INXN 1001; RG-115932; RG115932; RG 115932; N'-(3,5-dimethylbenzoyl)-N'-[(3R)-2,2-dimethylhexan-3-yl]-2-ethyl-3-methoxybenzohydrazide;(R)-N'-(3,5-dimethylbenzoyl)-N'-(2,2-dimethylhexan-3-yl)-2-ethyl-3-methoxybenzohydrazide. Grades: >98%. CAS No. 1093130-72-3. Molecular formula: C27H38N2O3. Mole weight: 438.61. | |
| Veledimex racemate | Veledimex racemate is the racemate of veledimex. Veledimex is an orally active small molecule diacylhydrazine and controls the expression of the target gene. Synonyms: N'-(3,5-dimethylbenzoyl)-N'-(2,2-dimethylhexan-3-yl)-2-ethyl-3-methoxybenzohydrazide; Veledimex (racemate). CAS No. 755013-59-3. Molecular formula: C27H38N2O3. Mole weight: 438.6. | |
| Veledimex S enantiomer | Veledimex S enantiomer is the S enantiomer of veledimex which is an orally active small molecule diacylhydrazine and controls the expression of the target gene. Synonyms: N'-(3,5-dimethylbenzoyl)-N'-[(3S)-2,2-dimethylhexan-3-yl]-2-ethyl-3-methoxybenzohydrazide; Veledimex (S enantiomer). CAS No. 1093131-03-3. Molecular formula: C27H38N2O3. Mole weight: 438.6. | |
| Veligrotug | Veligrotug is an IgG1-kappa, anti- IGF1R (insulin-like growth factor 1 receptor, CD221) chimeric monoclonal antibody [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 2728655-31-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990084. | |
| Velimogene aliplasmid | Velimogene aliplasmid. Uses: Designed for use in research and industrial production. Additional or Alternative Names: velimogene;Velimogene aliplasmid. Product Category: Heterocyclic Organic Compound. CAS No. 296251-72-4. Product ID: ACM296251724. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Veliparib | Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM, respectively. In HCT-116 and HT-29 cell lines, the ability of ABT-888 to synergize the effect of the anti-cancer agents, SN38 or oxaliplatin, was determined using the SRB assay. PARP activity was significantly reduced in samples treated with SN38 in combination with ABT-888 (>4 fold at 24 h). Uses: For research used only. Synonyms: (R)-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-4-carboxamide; ABT888; ABT-888; ABT 888; Veliparib. Grades: 0.99. CAS No. 912444-00-9. Molecular formula: C13H16N4O. Mole weight: 244.298. | |
| Veliparib | ABT-888 is a potent, orally bioavailable PARP-1/-2 inhibitor shown to potentiate DNA damaging agents. The ability to potentiate temozolomide (TMZ) and develop a biological marker for PARP inhibition was evaluated in vivo. Group: Biochemicals. Alternative Names: 2-[(2R)-2-Methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide; A 861695; ABT 888. Grades: Purified. CAS No. 912444-00-9. Pack Sizes: 10mg, 25mg, 50mg. US Biological Life Sciences. | Worldwide |
| Veliparib | Veliparib (ABT-888) is a potent PARP inhibitor, inhibiting PARP1 and PARP2 with K i s of 5.2 and 2.9 nM, respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: ABT-888. CAS No. 912444-00-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-10129. | |
| Veliparib dihydrochloride | Veliparib (dihydrochloride) is a potent inhibitor of PARP1 and PARP2 with K i s of 5.2 nM and 2.9 nM in cell-free assays, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: ABT-888 dihydrochloride. CAS No. 912445-05-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-10130. | |
| vellosimine dehydrogenase | Also acts on related alkaloids with an endo-aldehyde group as vellosimine (same stereochemistry at C-16) but only slight activity with exo-aldehydes. Detected in many cell suspension cultures of plants from the family Apocynaceae. Group: Enzymes. Enzyme Commission Number: EC 1.1.1.273. CAS No. 86777-26-6. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-0180; vellosimine dehydrogenase; EC 1.1.1.273; 86777-26-6. Cat No: EXWM-0180. |  |
| Velnacrine maleate | Velnacrine maleate (HP 029) is an orally active cholinesterase inhibitor that can be used for the research of Alzheimer's disease [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: HP 029; Hydroxytacrine maleate. CAS No. 118909-22-1. Pack Sizes: 25 mg; 50 mg; 100 mg. Product ID: HY-W011246. | |
| Velneperit | Velneperit is a once-daily, oral, centrally acting, small molecule neuropeptide Y (NPY) Y5 receptor antagonist. Uses: An optimized synthetic neuropeptide y (npy) y5 receptor antagonist used in the oral treatment of obesity. Synonyms: S-2367; S 2367; S2367; VelneperitN-[5-(Trifluoromethyl)pyridin-2-yl]-trans-4-(tert-butylsulfonylamino)cyclohexane-1-carboxamide. Grades: ≥98%. CAS No. 342577-38-2. Molecular formula: C17H24F3N3O3S. Mole weight: 407.45. | |
| Velneperit | Velneperit (S-2367) is a novel neuropeptide Y (NPY) Y5 receptor antagonist. Uses: Scientific research. Group: Signaling pathways. Alternative Names: S2367. CAS No. 342577-38-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-14423. | |
| Veloutone | Veloutone. CAS No. 65443-14-3. VIGON Item # 502847. Categories: Speciality Ingrdients Suppliers, Fragrances, fruity cyclopentanone, Perfumers. |  America & Internationally |
| Velpatasvir | Velpatasvir is a selective Hepatitis C virus NS 5 protein inhibitor originated by Gilead Sciences. It showed pan-genotypic activity and a high barrier to resistance in HCV replicon assays. Uses: Antiviral agents. Synonyms: GS5816; GS-5816; GS 5816; Velpatasvir; methyl ((R)-2-((2S, 4S)-2-(5-(2-((2S, 5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidin-2-yl)-1, 11-dihydroisochromeno[4', 3':6, 7]naphtho[1, 2-d]imidazol-9-yl)-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate. Grades: >98%. CAS No. 1377049-84-7. Molecular formula: C49H54N8O8. Mole weight: 883.01. | |
| Velpatasvir | Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC 50 of 2.16 μM [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: GS-5816. CAS No. 1377049-84-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-12530. | |
Our database is helping our users find suppliers everyday.
